As of 2025-09-18, the Intrinsic Value of Pharmadrug Inc (PHRX.CN) is -0.02 CAD. This PHRX.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.01 CAD, the upside of Pharmadrug Inc is -289.55%.
Based on its market price of 0.01 CAD and our intrinsic valuation, Pharmadrug Inc (PHRX.CN) is overvalued by 289.55%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.02 - -0.02 | -0.02 | -289.55% |
| DDM - Stable | (0.02) - (0.07) | (0.05) | -564.7% |
| DDM - Multi | (0.73) - (1.62) | (1.01) | -10169.1% |
| Market Cap (mil) | 1.57 |
| Beta | 1.01 |
| Outstanding shares (mil) | 156.84 |
| Enterprise Value (mil) | 2.87 |
| Market risk premium | 5.10% |
| Cost of Equity | 9.31% |
| Cost of Debt | 5.00% |
| WACC | 7.17% |